Impinj (PI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Executive summary
Annual Meeting scheduled for May 28, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 27, 2026.
Voting matters and shareholder proposals
Election of seven directors: Chris Diorio, Daniel Gibson, Umesh Padval, Steve Sanghi, Meera Rao, Arthur Valdez, Jr., and Miron Washington.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote to approve compensation of named executive officers.
Approval of the 2026 Equity Incentive Plan.
Proxies may vote on other business arising at the meeting or any adjournments.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Latest events from Impinj
- Q1 2026 beat guidance with $74.3M revenue and record endpoint IC bookings; Q2 outlook strong.PI
Q1 202630 Apr 2026 - Board recommends all proposals, including a new equity plan and robust governance measures.PI
Proxy filing16 Apr 2026 - Record adjusted EBITDA and cash in 2025; new products and solutions to drive 2026 growth.PI
Q4 202512 Apr 2026 - Record Q2 revenue and EBITDA, driven by licensing and endpoint ICs; Q3 outlook remains positive.PI
Q2 20243 Feb 2026 - All proposals passed and directors re-elected, with no shareholder questions raised.PI
AGM 20242 Feb 2026 - General merchandise and retail recovery, M800 chip ramp, and new use cases drive growth.PI
Baird 2024 Global Consumer, Technology, & Services Conference31 Jan 2026 - General merchandise and food tagging drive growth as M800 chip boosts margins and RFID use cases expand.PI
Piper Sandler Growth Frontiers Conference21 Jan 2026 - Retail, food, and regulatory drivers fuel RFID growth, with financial targets reaffirmed.PI
Goldman Sachs Communacopia + Technology Conference 202420 Jan 2026 - Q3 revenue up 46% year-over-year, net income positive, strong endpoint IC sales and outlook.PI
Q3 202419 Jan 2026